SPL Ann: VIRALEZE Post-Market Clinical Study in COVID-19 Patients - 8th Dec 2022, 9:36am

annb0t

annb0t

Top 20
SPL Ann: VIRALEZE Post-Market Clinical Study in COVID-19 Patients
Price Sensitive: N
Date: 8th Dec 2022, 9:36am

>>> Read announcement: Google: SPL Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
SPL Ann: VIRALEZE Nasal Spray Approved in Malaysia - 5th Jun 2023, 9:45am
Replies
0
Views
77
annb0t
annb0t
annb0t
SPL Ann: VIRALEZE Nasal Spray Registered in Indonesia - 14th Dec 2022, 11:04am
Replies
0
Views
238
annb0t
annb0t
annb0t
SPL Ann: VIRALEZE launched in Hong Kong and Macau - 21st Nov 2022, 9:58am
Replies
0
Views
119
annb0t
annb0t
annb0t
SPL Ann: VIRALEZE distribution agreement for Hong Kong and Macau - 21st Oct 2022, 9:42am
Replies
0
Views
160
annb0t
annb0t
annb0t
SPL Ann: VIRALEZE Protects Against Omicron in Viral Challenge Model - 20th Jul 2022, 10:35am
Replies
0
Views
200
annb0t
annb0t
Top Bottom